(Date:11/24/2009)...PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: S...today,announcedthatithassubmittedaMAAtotheEuropean...nzymereplacementtherapyindevelopment,forthetreatme...plicationforvelaglucerasealfathathasbeensubmitted,.... , Basedonaglobalsupplyshortageofthecurrentl...
(Date:11/24/2009)...Program Connects Customers with Partners Validated... Genotek Products , Ottaw...a leading provider of products for biological samp...y announced its new global partner program. The pr...tek,s partner community and is designed to help pa...
(Date:11/23/2009)... think of it as origami very high-tech origami. ,...eveloped a technique for fabricating three-dimensi...hin films by coupling photolithography and a self-..., The films, only a few microns thick, offer mech...er pieces of the same material. , "This is a comp...
(Date:11/23/2009)....23/PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAm...mpanythatidentifiesandadvancesadiverseportfolioofp...elopment,todayreportedthatCytopia(ASX:CYT)hascomme...otent,orally-administeredJAK1/JAK2inhibitor.Thetri...a.AproposaltomergeCytopiaintoYMhasbeenpreviouslyan...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Water droplets direct self-assembly process in thin-film materials 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4...genetic anticancer program at Pharmion - L... - Sirtuins implicated in tumor developmen...re combination epigenetic therapies, BOULDER, Col...sdaq: PHRM ) and MethylGene Inc. (TSX: MYG) today...pment of novel small molecule,inhibitors targeting...
... CLAREMONT, Calif., Aug. 14 /Xinhua-PRNewswire-Fir...n (OTC Bulletin Board: KWBT),announced that revenu...han,35% over the first quarter of 2007 exceeding $...351 for the same period in the previous year. Rev...ompared to only,$24,374 in the first half of 2006....
...d., Aug. 14 Martek Biosciences,Corporation announ...third,quarter of fiscal 2007 on September 5, 2007,...(EDT). Following the release, at 4:45 p.m. EDT Mar...ults of its third quarter of,fiscal 2007 with inve...e,hour in duration. The conference call will also ...
Other Biology Technology:Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 2Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 3Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 4Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 5Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents 6Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 2Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 3Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 4Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 5Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million 6Martek to Announce Third Quarter 2007 Results on September 5, 2007 2...s of cancer continues to pose a major problem for ... forms of chemotherapy or become resistant to the ... Infection Research (HZI) in Braunschweig, the Han...(LUH) in Hanover have now discovered a chemical me... destroys tumours. Today, the researchers publish ...
...of on-the-go crop and soil sensors has greatly inc... their crops. Recently released research in Agron...ment is necessarily more efficient. They discovere...recision agriculture, calculating how large of an ...nt techniques. According to the authors, this chan...
...h . , Barcelona, Spain: Couples who need IVF i...his will not lead to developmental problems in ear...l conference of the European Society of Human Repr.... Karin Middelburg, from the University Medical Ce...hat the study, which looked at the quality of gene...
Other Biology News:Argyrin: Natural substance raises hope for new cancer therapies 2IVF does not increase risk of developmental disorders in children 2Feline IFN-alpha, Unconjugated from R&D Systems
Rat Anti-CCR5 Monoclonal Antibody, Unconjugated, Clone HEK / 1 / 85a from Abcam
Mouse Anti-Chloramphenicol Acetyltransferase Monoclonal Antibody, Unconjugated, Clone CAT-1 from Abcam
Anti-Notch 1, cleaved (Val1744) Antibody, Unconjugated from Cell Signaling Technology
Biology Products: